N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide

C80H96N24O12S4 — CID 157261401

IUPACN-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide
SMILESCC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1
InChIInChI=1S/4C20H24N6O3S/c2*1-12-10-15(4-7-21-12)26-17(28)20(24-19(26)29)5-8-25(9-6-20)13(2)16-11-22-18(30-16)23-14(3)27;2*1-12-4-5-15(10-21-12)26-17(28)20(24-19(26)29)6-8-25(9-7-20)13(2)16-11-22-18(30-16)23-14(3)27/h2*4,7,10-11,13H,5-6,8-9H2,1-3H3,(H,24,29)(H,22,23,27);2*4-5,10-11,13H,6-9H2,1-3H3,(H,24,29)(H,22,23,27)/t4*13-/m1010/s1
InChIKeyAXMSQAMQUINWGE-QGLFRBIFSA-N
MW1714.07 g/mol
LogP9.83
Rot. Bonds16

About N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide

N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide (PubChem CID 157261401) has the molecular formula C80H96N24O12S4 and a molecular weight of 1714.07 g/mol. Its IUPAC name is N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide.

Molecular Properties

Compound NameN-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide
PubChem CID157261401
Molecular FormulaC80H96N24O12S4
Molecular Weight1714.07 g/mol
Exact Mass1712.65
IUPAC NameN-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide
SMILESCC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1
InChIInChI=1S/4C20H24N6O3S/c2*1-12-10-15(4-7-21-12)26-17(28)20(24-19(26)29)5-8-25(9-6-20)13(2)16-11-22-18(30-16)23-14(3)27;2*1-12-4-5-15(10-21-12)26-17(28)20(24-19(26)29)6-8-25(9-7-20)13(2)16-11-22-18(30-16)23-14(3)27/h2*4,7,10-11,13H,5-6,8-9H2,1-3H3,(H,24,29)(H,22,23,27);2*4-5,10-11,13H,6-9H2,1-3H3,(H,24,29)(H,22,23,27)/t4*13-/m1010/s1
InChIKeyAXMSQAMQUINWGE-QGLFRBIFSA-N
XLogP9.83
TPSA430.12 Ų
H-Bond Donors8
H-Bond Acceptors28
Rotatable Bonds16
Heavy Atoms120
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001714.07
LogP ≤ 59.83
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide?
The IUPAC name of N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide (CID 157261401) is N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide.
What is the SMILES notation for N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide?
The canonical SMILES for N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide is CC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccc(C)nc2)C3=O)s1.CC(=O)Nc1ncc([C@H](C)N2CCC3(CC2)NC(=O)N(c2ccnc(C)c2)C3=O)s1.
What is the InChIKey of N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide?
The InChIKey is AXMSQAMQUINWGE-QGLFRBIFSA-N. The full InChI is InChI=1S/4C20H24N6O3S/c2*1-12-10-15(4-7-21-12)26-17(28)20(24-19(26)29)5-8-25(9-6-20)13(2)16-11-22-18(30-16)23-14(3)27;2*1-12-4-5-15(10-21-12)26-17(28)20(24-19(26)29)6-8-25(9-7-20)13(2)16-11-22-18(30-16)23-14(3)27/h2*4,7,10-11,13H,5-6,8-9H2,1-3H3,(H,24,29)(H,22,23,27);2*4-5,10-11,13H,6-9H2,1-3H3,(H,24,29)(H,22,23,27)/t4*13-/m1010/s1.
What are the key properties of N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide?
N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide has a molecular weight of 1714.07 g/mol, XLogP of 9.83, 16 rotatable bonds, 8 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[(1R)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(2-methyl-4-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1R)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide;N-[5-[(1S)-1-[3-(6-methyl-3-pyridinyl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl]ethyl]-1,3-thiazol-2-yl]acetamide is sourced from PubChem (CID 157261401), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).